|
|
|||||||||||
Division of Psychological Medicine, Institute of Psychiatry, Kings College London, UK and Department of Psychiatry, University of Athens, Greece
Division of Psychological Medicine, Institute of Psychiatry, Kings College London, UK
Division of Psychological Medicine, Institute of Psychiatry, Kings College London, UK and Department of Psychiatry, National University of Ireland, Galway, Ireland
Division of Psychological Medicine, Institute of Psychiatry, Kings College London, UK
Department of Psychiatry, Landspitalinn, The University Hospital, Reykjavik, Iceland
Division of Psychological Medicine, Institute of Psychiatry, Kings College London, UK
Mount Carmel Hospital, Attard, Malta
Division of Psychological Medicine, Institute of Psychiatry, Kings College London, UK
Division of Psychological Medicine, Institute of Psychiatry, Kings College London, UK
Division of Psychological Medicine, Institute of Psychiatry, Kings College London, UK and Department of Psychiatry, University of Hong Kong
Correspondence: Dr Dimitris G. Dikeos, Institute of Psychiatry, SGDP Building, De Crespigny Park, Denmark Hill, London SE5 8AF, UK. Tel: +44(0)20 7848 0854; email d.dikeos{at}iop.kcl.ac.uk
Declaration of interest None. Funding detailed in Acknowledgements.
|
|
ABSTRACT |
|---|
|
|
|---|
Aims To examine the structure of dimensionsin psychosis, to analyse their correlations with disease characteristics and to assess the relative contribution of dimensions v. diagnosis in explaining these characteristics.
Method Factor analysis of the OPCRIT items of 191 Maudsley Family Study patients with schizophrenia, mood disorders with psychosis, schizoaffective disorder, and other psychotic illnesses, followed by regression of disease characteristics from factor scores and diagnosis.
Results Five factors were identified (mania, reality distortion, depression, disorganisation, negative); all were more variable in schizophrenia than in affective psychosis. Mania was the best discriminator between schizophrenia and affective psychosis; the negative factor was strongly correlated with poor premorbid functioning, insidious onset and worse course. Dimensions explained more of the disease characteristics than did diagnosis, but the explanatory power of the latter was also high.
Conclusions Kraepelinian diagnostic categories suffice for understanding illness characteristics, but the use of dimensions adds substantial information.
|
|
INTRODUCTION |
|---|
|
|
|---|
The first aim of the present study was to examine the factor structure in a population of people with psychosis, including patients with schizophrenia, schizoaffective disorder and mood disorders, and to identify differences between diagnostic groups regarding the factors. Our second aim was to check for correlations between the factors and various clinical characteristics before and after taking into account the diagnostic category to which the participants belonged. Our third aim was to assess the relative contribution of the dimensional v. the categorical diagnostic approach in explaining disease characteristics.
|
|
METHOD |
|---|
|
|
|---|
For all 191 patients who were included in the analysis (Table 1), Research Diagnostic Criteria (RDC; Spitzer et al, 1978) and DSMIV (American Psychiatric Association, 1994) diagnoses were made using a modified version of the Schedule for Affective Disorders and Schizophrenia Lifetime version (Endicott & Spitzer, 1978) in face-to-face interviews with experienced psychiatrists (C.McD, T.S., A.G., E.B.). Additional information regarding psychopathology was obtained from family members and hospital records where available. The OPCRIT files were filled in by two experienced psychiatrists (H.W., D.D.) who reviewed all material. In case of uncertainty, the final rating was decided after a discussion between the two raters and a third expert (C.McD.).
|
Extraction of factors and calculation of factor scores
In all, 51 OPCRIT items referring to symptoms entered the analysis as
variables taking a value of 0 (symptom not present) or 1. Items referring to
data collection and communication with sources of information (items 1, 2, 84
and 86), demographic variables (item 3), premorbid characteristics (items 6,
7, 911), potential aetiological correlates and comorbidity (items
1216, 7883), and onset and course of the disorder (items 4, 5,
8, 8790) were not included in the factor analysis, but the correlation
of factor scores with most of these items was later explored. Items 52, 64 and
65 (which refer to relationship between symptoms covered by other items) and
items 38 and 40 (diurnal mood variation and diminished libido which, for many
participants, could not be reliably retrieved) were also excluded from the
analysis. Sleep disorders (insomnia and/or hypersomnia items
4447) and problems with appetite and/or weight (reduced or increased
appetite with or without weight change items 4851) entered the
analysis as two variables referring overall to each one of these
conditions.
Extraction of factors was based on principal component analysis of correlation matrix and varimax rotation. Missing values (only 5 respondents of the 191 had more than five variables missing and none more than eight variables) were replaced with sample means. Regression factor scores were then calculated for each participant using the standard option within the Statistical Package for the Social Sciences, version 11.5 factor analysis procedure. The mean scores of factors were compared between the two main diagnostic groups, i.e. schizophrenia and mood disorder with psychosis (affective psychosis), and the factor scores were plotted in bar charts with participants grouped according to their diagnosis. Finally, a discriminant analysis was performed with diagnosis (schizophrenia or affective psychosis) as grouping variable and the five factor scores as independent variables.
Correlation of factor scores with characteristics of history and course
The clinical parameters examined for their relation to the factor scores
were those referring to premorbid characteristics (work and social adjustment,
personality disorder, presence of potential stressor associated with onset),
onset (age at onset, mode of onset), and course (impairment during the
episodes or exacerbations, quality of remissions between episodes or
exacerbations, deterioration from the premorbid level of functioning, response
to neuroleptics, overall course); these items were rated according to the
OPCRIT definitions.
Each clinical characteristic was the dependent variable in two sets of regression analyses (linear, logistic or ordinal, as appropriate), and the factor scores were the independent variables; confounding factors were gender and age in the first set, and gender, age and diagnosis in the second. The relative contribution of factor scores v. that of categorical diagnosis in explaining the variability of clinical characteristics was assessed by comparing regression models.
Appropriate Bonferroni corrections for repeat measurements were applied wherever necessary.
|
|
RESULTS |
|---|
|
|
|---|
|
The mean score of each of the five factors differed significantly between the two main diagnostic groups, with scores of mania and depression being higher in participants with mood disorders, and scores of the other three factors being higher in participants with schizophrenia.
The discriminant analysis with diagnosis (schizophrenia or mood disorders) as grouping variable, and the five factor scores as independent variables, classified correctly 97.7% of the respondents with schizophrenia and 95.3% of the respondents with mood disorder, corresponding to 86.9% of the total sample.
Distribution of factor scores
In the overall sample the distribution of mania and negative symptoms
factors seemed to be bimodal, whereas the distribution of the other three
factors was unimodal. The distribution of factor scores in participants with
schizophrenia and mood disorders, separated according to diagnosis, is shown
in Fig. 1.
|
Correlation of factor scores with other clinical characteristics which were not included in the factor analysis
Factor scores did not show any significant association with gender or age
when diagnosis was controlled by regression. Similarly, they were not
different between familial and non-familial participants.
Statistical analysis of the relationship of factor scores and clinical characteristics relating to premorbid features, onset and course before and after controlling for diagnosis is presented in Table 3.
|
The majority of correlations that were significant after controlling for diagnosis related to people with schizophrenia. The strongest association between a factor score and a clinical characteristic was that of negative factor score and course among participants with schizophrenia (ordinal regression controlling for gender and age P<0.001, after controlling for multiple testing); this association is depicted in Fig. 2.
|
|
|
|
DISCUSSION |
|---|
|
|
|---|
The five-factor solution that we chose as best fitting to our data is comparable with that proposed by many other studies on psychosis (Lindenmayer et al, 1995a,b; Nakaya et al, 1999; Lykouras et al, 2000; Mass et al, 2000; Ehmann et al, 2001; Wickham et al, 2001; Drake et al, 2003; Good et al, 2004; Lindenmayer et al, 2004). Of the recent studies which have assessed the dimensions of mixed diagnostic samples of patients with schizophrenia spectrum and patients with mood disorder, the five-factor model has been chosen as the most appropriate in some (van Os et al, 1999; Wickham et al, 2001; Lindenmayer et al, 2004) and a four-factor model in others (McGorry et al, 1998; Serretti et al, 2001). In the first of the latter studies, the four-factor model was chosen because psychotic symptoms were examined from the Bleulerian v. the Schneiderian perspective, and both negative and disorganisation symptoms fall into the first of these categories (McGorry et al, 1998). In the study of Serretti et al (2001), the negative symptoms factor was not distinguished from disorganisation, but the item restricted affect was excluded from the analysis because of high correlation with blunted affect, which might have had an important impact on the negative symptoms factor when the analysis was based on OPCRIT data. Items loading to the negative symptoms factor in the OPCRIT were few, but inspection of their factor loading scores (Table 2) shows the negative factor to be quite robust. This was further supported when we attempted the four-factor solution, where the items contributing to the negative factor and their loadings stayed practically unchanged, whereas the disorganisation factor dissolved.
Thus, we believe that the five-factor model is the most appropriate to explain the variance in the symptoms of our sample.
Distribution of factor scores
The score on the mania factor seems the best discriminator between
schizophrenia and mood disorders (Fig.
1). For depression, reality distortion and disorganisation factor
scores there is considerable overlap of participants with schizophrenia and
those with mood disorders, although mean values differ between the two groups.
For the negative symptoms factor, the scores of respondents with mood
disorders are at about the middle of the range, whereas the scores of
respondents with schizophrenia vary more widely.
In general, the score of people with schizophrenia has a much wider distribution than the score of people with mood disorders, implying that bipolar disorder is a much more solid construct than schizophrenia, which appears to be heterogeneous. Negative symptoms, in particular, have a bimodal distribution among people with schizophrenia, suggesting two different latent sub-categories of the disease.
Five studies provide some description of the factor structure by diagnostic category. Intra-group variation of factor scores and considerable overlap between diagnostic groups is cited by van Os et al (1996). In the study by Ratakonda et al (1998) the patients with schizophrenia scored higher in the negative symptoms factor and the positive factor and, to a lesser extent, also in the disorganisation factor, than the patients without schizophrenia. The latter group, however, was a mixed diagnostic group including 65 individuals with mood disorders, 16 with delusional disorder and 21 with various other psychotic disorders (Ratakonda et al, 1998). As in our study, the participants with affective psychosis were found to score higher in mania and depression and lower in positive and negative symptom factors, with considerable overlap between diagnostic categories in the van Os et al (1999) study, but no detailed presentation of the factor distributions was made. Factor score distribution across categories of individuals with affective psychosis v. non-affective psychosis is presented in the van Os et al (2000) study. The overlap of scores for negative symptom, disorganisation and positive symptom factors is much greater than the respective overlap in our sample; the inclusion of patients with schizoaffective disorder in the affective psychosis group of the van Os et al study may be an explanation for this. In the most recent study by Lindenmayer et al (2004), the factors were derived by separate analyses for the diagnostic groups of schizophrenia and mood disorders, and only a few differences in symptoms between the diagnostic groups are mentioned.
Correlation of factor scores with other clinical characteristics which were not included in the factor analysis
Mania, reality distortion and disorganisation factor scores are associated
with various clinical characteristics, but most of these associations are lost
when diagnosis is controlled for by multiple regression
(Table 3). The negative
symptoms factor score is the only factor score which shows significant
associations with more than one of the clinical characteristics when gender,
age and diagnosis are controlled for and multiple testing is taken into
account. Negative symptoms factor score is positively associated with poor
premorbid performance (social and occupational), premorbid personality
disorder, more insidious onset, bad remissions or no recovery between
episodes, no response to neuroleptics, and worse course of the illness.
Those associations the significance of which is lost after controlling for diagnosis are mainly concerned with differences between diagnostic groups (of schizophrenia v. mood disorder), and do not reflect a real relation between the factor score and the clinical characteristic other than that which connects the clinical characteristic with a specific diagnosis.
In all eight other studies, which examined the correlation between psychopathological dimensions and clinical characteristics, the negative factor was found to be associated with at least one characteristic indicating either poor premorbid functioning (Gureje et al, 1995; Lenzenweger & Dworkin, 1996; Ratakonda et al, 1998; Wickham et al, 2001; Kulhara & Avasthi, 2003), earlier or insidious onset (van Os et al, 1996; Ratakonda et al, 1998; Sato et al, 1998; Sato et al, 2004), or deteriorating/chronic course (van Os et al, 1996; Marengo et al, 2000; Wickham et al, 2001). The dimension of disorganisation has been found to be associated with the same characteristics as the negative symptoms dimension in five out of the eight studies (Gureje et al, 1995; Lenzenweger & Dworkin, 1996; van Os et al, 1996; Ratakonda et al, 1998; Wickham et al, 2001); the strength of correlations, however, was less strong than that of the negative symptoms dimension (van Os et al, 1996; Wickham et al, 2001), as was the case in our study. The reality distortion dimension was found in three studies to be associated with a deteriorating/chronic course or (not very strongly) with a bad outcome (van Os et al, 1996; Ratakonda et al, 1998; Wickham et al, 2001). In our study, we observed an association of the reality distortion factor with poor premorbid adjustment and poor course, but these correlations were lost when diagnosis was controlled for. It seems, thus, that the findings relating reality distortion to a more severe disorder could be attributed to differences among the various diagnostic groups of patients of the three studies, all of which contained mixed populations of people with psychosis (van Os et al, 1996; Ratakonda et al, 1998; Wickham et al, 2001). In the only study that included people with schizophrenia only, reality distortion was associated with better premorbid adjustment, suggesting that among patients belonging to one diagnostic category its presence might be an indicator of milder disease (Lenzenweger & Dworkin, 1996). The depressive symptoms dimension has not been found in any other study to be related to another clinical characteristic, which is in accordance with our results. Finally, in one study the mania dimension was found to be associated with a better course, a finding which was similar to what was observed in the present study, and which was markedly attenuated when diagnosis was taken into account (van Os et al, 1996).
Thus, it seems that our results are quite similar to those of previous studies, particularly if differences between diagnoses are taken into account. It should be noted, however, that direct comparisons with previous findings cannot be made, since the current analysis was based on global premorbid and retrospective items on course and outcome, whereas prospective follow-up measures or detailed measures of need were used in other papers.
Relative contributions of diagnosis and factor scores to the explanation of the variability of clinical characteristics
According to the comparison between regression models, diagnosis seems to
explain by itself the large majority of clinical characteristics that were
examined. Factor scores were found to add to the explanation of the
variability of these characteristics, even when diagnosis had already been
taken into account. On the other hand, when factor scores were first used to
explain the variability of the clinical picture, diagnosis did not seem to add
anything to the explanation. It appears, thus, that the Kraepelinian
subdivision can be almost perfectly derived from the five symptom dimensions,
as was also shown by the results of the discriminant analysis we
performed.
Categorical v. dimensional approaches were compared in a number of studies, generally showing (as was the case in our study) that dimensions are more useful than diagnostic categories as predictors of clinical course and treatment decisions (van Os et al, 1996, 1999; Peralta et al, 2002; Rosenman et al, 2003).
The finding that dimensions explain more of the clinical characteristics, course, and use of services than do diagnoses, has led to proposals that the dimensional approach should be considered indispensable for clinical management, alongside the use of categorical diagnosis (van Os et al, 1999; Salokangas et al, 2002; Rosenman et al, 2003; van Os & Verdoux, 2003). Our findings, however, show that the number of clinical characteristics whose variability is explained to a satisfactory level by diagnosis alone is quite high, and does not fall short of the number of characteristics the variability of which is explained by the factors alone. Furthermore, in the studies by Peralta et al (2002) and Rosenman et al (2003), the difference in the explanatory potential of diagnosis v. that of dimensions was overall not very large, indicating that categorical diagnoses as used today in psychiatry are quite robust and convey a large amount of information. In that sense, the diagnostic categories which are available seem to be sufficient as a first-order approximation, given also that their use is the most cost-effective approach for communication between clinicians and initial understanding of the patient. On the other hand, since dimensions are generally found to add to the information contained in diagnosis, the dimensional approach offers a much better perspective into the symptoms and characteristics of the illness, and is useful for an in-depth understanding of the individual patient and for research purposes.
General comments and conclusions
There are some limitations to the present study. First, the sample is
relatively small and was recruited for the special purpose of a family study.
Individuals with mood disorders, in particular, were selected only if they
also had exhibited psychotic symptoms, whereas the sample of participants with
diagnoses other than schizophrenia or mood disorders was rather small. On the
other hand, this recruitment procedure meant that all participants have been
very rigorously examined by the same few individuals. Another limitation of
the study is that it relies on retrospective rather than prospective data.
In spite of these limitations, various conclusions can be drawn. A five-dimension structure comprising mania, reality distortion, depression, disorganisation and negative symptoms seems to be most appropriate to explain the symptoms of people with psychosis. The scores of all factors are more variable in schizophrenia than in mood disorders, mania is the best discriminator between schizophrenia and affective psychosis, and the factor of negative symptoms is bimodal in schizophrenia. In addition, the negative symptoms factor seems to be the most robust of all, with its scores strongly correlated to various other clinical factors that relate to premorbid features, onset and course of the disorder. Finally, the contribution of factors to the understanding of symptoms of a given individual is found to be important, although it is also shown that the contribution of Kraepelinian diagnosis is quite high as well.
|
|
ACKNOWLEDGMENTS |
|---|
|
|
|---|
|
|
REFERENCES |
|---|
|
|
|---|
Drake, R. J., Dunn, G., Tarrier, N., et al (2003) The evolution of symptoms in the early course of non-affective psychosis. Schizophrenia Research, 63, 171 179.[CrossRef][Medline]
Ehmann, T. S., Holliday, S. G., MacEwan, G. W., et al (2001) Multidimensional assessment of psychosis: a factor-analytic validation study of the Routine Assessment of Patient Progress. Comprehensive Psychiatry, 42, 32 38.[CrossRef][Medline]
Endicott, J. & Spitzer, R. L. (1978) A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Archives of General Psychiatry, 35, 837 844.[Abstract]
Frangou, S., Sharma, T., Sigmundsson, T., et al
(1997) The Maudsley Family Study. 4. Normal planum temporale
asymmetry in familial schizophrenia. A volumetric MRI study.
British Journal of Psychiatry,
170, 328
333.
Good, K. P., Rabinowitz, J., Whitehorn, D., et al (2004) The relationship of neuropsychological test performance with the PANSS in antipsychotic naive, first-episode episode psychosis patients. Schizophrenia Research, 68, 11 19.[CrossRef][Medline]
Gureje, O., Aderibigbe, Y. A. & Obikoya, O. (1995) Three syndromes in schizophrenia: validity in young patients with recent onset of illness. Psychological Medicine, 25, 715 725.[Medline]
Kulhara, P. & Avasthi, A. (2003) Influence of depressive symptoms and premorbid adjustment on factor structure of phenomenology of schizophrenia: a study from India. European Psychiatry, 18, 226 232.[CrossRef][Medline]
Lenzenweger, M. F. & Dworkin, R. H. (1996)
The dimensions of schizophrenia phenomenology. Not one or two, at least three,
perhaps four. British Journal of Psychiatry,
168, 432
440.
Lindenmayer, J. P., Brown, E., Baker, R. W., et al (2004) An excitement subscale of the Positive and Negative Syndrome Scale. Schizophrenia Research, 68, 331 337.[CrossRef][Medline]
Lindenmayer, J. P., Bernstein-Hyman, R., Grochowski, S., et al (1995a) Psychopathology of schizophrenia: initial validation of a 5-factor model. Psychopathology, 28, 22 31.[Medline]
Lindenmayer, J. P., Grochowski, S. & Hyman, R. B. (1995b) Five factor model of schizophrenia: replication across samples. Schizophrenia Research, 14, 229 234.[CrossRef][Medline]
Lykouras, L., Oulis, P., Psarros, K., et al (2000) Five-factor model of schizophrenic psychopathology: how valid is it? European Archives of Psychiatry and Clinical Neuroscience, 250, 93 100.[CrossRef][Medline]
Marengo, J., Harrow, M., Herbener, E. S., et al (2000) A prospective longitudinal 10-year study of schizophrenias three major factors and depression. Psychiatry Research, 97, 61 77.[CrossRef][Medline]
Mass, R., Schoemig, T., Hitschfeld, K., et al
(2000) Psychopathological syndromes of schizophrenia:
evaluation of the dimensional structure of the positive and negative syndrome
scale. Schizophrenia Bulletin,
26, 167
177.
McDonald, C., Bullmore, E. T., Sham, P. C., et al
(2004) Association of genetic risks for schizophrenia and
bipolar disorder with specific and generic brain structural endophenotypes.
Archives of General Psychiatry,
61, 974
984.
McDonald, C., Bullmore, E., Sham, P., et al
(2005) Regional volume deviations of brain structure in
schizophrenia and psychotic bipolar disorder: computational morphometry study.
British Journal of Psychiatry,
186, 369
377.
McGorry, P. D., Bell, R. C., Dudgeon, P. L., et al (1998) The dimensional structure of first episode psychosis: an exploratory factor analysis. Psychological Medicine, 28, 935 947.[CrossRef][Medline]
McGuffin, P., Farmer, A. & Harvey, I. (1991) A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Archives of General Psychiatry, 48 764 770.[Medline]
Morgan, C., Mallett, R., Hutchinson, G., et al
(2005) Pathways to care and ethnicity. 1: Sample
characteristics and compulsory admission. Report from the ÆSOP study.
British Journal of Psychiatry,
186, 281
289.
Nakaya, M., Suwa, H. & Ohmori, K. (1999) Latent structures underlying schizophrenic symptoms: a five-dimensional model. Schizophrenia Research, 39, 39 50.[CrossRef][Medline]
Peralta, V., Cuesta, M. J., Giraldo, C., et al (2002) Classifying psychotic disorders; issues regarding categorial vs. dimensional approaches and time frame to assess symptoms. European Archives of Psychiatry and Clinical Neuroscience, 252, 12 18.[Medline]
Ratakonda,, S., Gorman, J. M., Yale, S. A. et al
(1998) Characterization of psychotic conditions. Use of the
domains of psychopathology model. Archives of General
Psychiatry, 55, 75
81.
Rosenman, S., Korten, A., Medway, J., et al (2003) Dimensional vs. categorical diagnosis in psychosis. Acta Psychiatrica Scandinavica, 107, 378 384.[CrossRef][Medline]
Salokangas, R. K., Honkonen, T., Stengard, E., et al (2002) Symptom dimensions and their association with outcome and treatment setting in long-term schizophrenia. Results of the DSP project. Nordic Journal of Psychiatry, 56, 319 327.[CrossRef][Medline]
Sato, T., Bottlender, R., Schroter, A., et al (2004) Psychopathology of early-onset versus late-onset schizophrenia revisited: an observation of 473 neuroleptic-naive patients before and after first-admission treatments. Schizophrenia Research, 67, 175 183.[CrossRef][Medline]
Serretti, A., Rietschel, M., Lattuada, E., et al (2001) Major psychoses symptomatology: factor analysis of 2241 psychotic subjects. European Archives of Psychiatry and Clinical Neuroscience, 251, 193 198.[CrossRef][Medline]
Spitzer, R. L., Endicott, J. & Robins, E. (1978) Research Diagnostic Criteria: rationale and reliability. Archives of General Psychiatry, 35, 773 782.[Abstract]
Toomey, R., Faraone, S. V., Simpson, J. C., et al (1998) Negative, positive, and disorganized symptom dimensions in schizophrenia, major depression, and bipolar disorder. Journal of Nervous and Mental Disease, 186, 470 476.[CrossRef][Medline]
Toulopoulou, T., Rabe-Hesketh, S., King, H., et al (2003) Episodic memory in schizophrenic patients and their relatives. Schizophrenia Research, 63, 261 271.[CrossRef][Medline]
van Os, J., Fahy, T. A., Jones, P., et al (1996) Psychopathological syndromes in the functional psychoses: associations with course and outcome. Psychological Medicine, 26, 161 176.[Medline]
van Os., J., Gilvarry, C., Bale, R., et al (1999) A comparison of the utility of dimensional and categorical representations of psychosis. UK700 Group. Psychological Medicine, 29, 595 606.[CrossRef][Medline]
van Os, J., Gilvarry, C., Bale, R., et al (2000) Diagnostic value of the DSM and ICD categories of psychosis: an evidence-based approach. UK700 Group. Social Psychiatry and Psychiatric Epidemiology, 35, 305 311.[CrossRef][Medline]
van Os, J. & Verdoux, H. (2003) Diagnosis and classification in schizophrenia: categories versus dimensions, distributions versus disease. In The Epidemiology Of Schizophrenia (eds R. M. Murray, P. B. Jones, E. Susser, et al), pp. 364410. Cambridge: Cambridge University Press.
Ventura, J., Nuechterlein, K. H., Subotnik, K. L., et al (2000) Symptom dimensions in recent-onset schizophrenia and mania: a principal components analysis of the 24-item Brief Psychiatric Rating Scale. Psychiatry Research, 97, 129 135.[CrossRef][Medline]
Wickham, H., Walsh, C., Asherson, P., et al (2001) Familiality of symptom dimensions in schizophrenia. Schizophrenia Research, 47, 223 232.[CrossRef][Medline]
Received for publication September 19, 2005. Revision received April 4, 2006. Accepted for publication May 2, 2006.
This article has been cited by other articles:
![]() |
E. Vassos, P. C. Sham, G. Cai, H. Deng, X. Liu, X. Sun, J. Zhao, R. M. Murray, D. A. Collier, and T. Li Correlation and familial aggregation of dimensions of psychosis in affected sibling pairs from China The British Journal of Psychiatry, October 1, 2008; 193(4): 305 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Tyrer From the Editor's desk The British Journal of Psychiatry, September 1, 2008; 193(3): 266 - 266. [Full Text] [PDF] |
||||
![]() |
E. Ivleva, G. Thaker, and C. A. Tamminga Comparing Genes and Phenomenology in the Major Psychoses: Schizophrenia and Bipolar 1 Disorder Schizophr Bull, July 1, 2008; 34(4): 734 - 742. [Full Text] [PDF] |
||||
![]() |
J. Allardyce, W. Gaebel, J. Zielasek, and J. van Os Deconstructing Psychosis Conference February 2006: The Validity of Schizophrenia and Alternative Approaches to the Classification of Psychosis Schizophr Bull, July 1, 2007; 33(4): 863 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dutta, T. Greene, J. Addington, K. McKenzie, M. Phillips, and R. M. Murray Biological, Life Course, and Cross-Cultural Studies All point Toward the Value of Dimensional and Developmental Ratings in the Classification of Psychosis Schizophr Bull, July 1, 2007; 33(4): 868 - 876. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Craddock, M. C. O'Donovan, and M. J. Owen Symptom dimensions and the Kraepelinian dichotomy The British Journal of Psychiatry, April 1, 2007; 190(4): 361 - 361. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |